Matthews China Active ETF (MCH) Chart & Stock Price History → Why Big Pharma is Investing Billions in This Biotech (From Behind the Markets) (Ad) Free MCH Stock Alerts $19.95 +0.51 (+2.62%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Matthews China Active ETF Stock Price Performance5 Day Performance+6.09%1 Month Performance+7.11%3 Month Performance+11.16%6 Month Performance+3.07%Year-To-Date Performance+4.82%1 Year Performance-10.56% Receive MCH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Matthews China Active ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy MCH Stock Chart for Saturday, April, 27, 2024 MCH Chart by TradingView Matthews China Active ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$19.44$19.95+2.62%$19.95$19.8711,424 shs$21.95 million04/25/2024$19.35$19.44+0.47%$19.44$19.285,184 shs$21.38 million04/24/2024$19.09$19.35+1.36%$19.35$19.278,168 shs$21.29 million04/23/2024$18.81$19.09+1.49%$19.09$18.997,643 shs$21.00 million04/22/2024$18.37$18.81+2.40%$18.82$18.647,216 shs$20.69 million04/19/2024$18.48$18.37-0.60%$18.37$18.323,558 shs$20.21 million Get the Latest News and Ratings for MCH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Matthews China Active ETF and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$18.32$18.48+0.87%$18.56$18.4812,515 shs$20.33 million04/17/2024$18.29$18.32+0.16%$18.37$18.315,441 shs$20.15 million04/16/2024$18.48$18.29-1.03%$18.34$18.2321,949 shs$20.12 million04/15/2024$18.36$18.48+0.66%$18.66$18.4320,427 shs$20.33 million04/12/2024$19.01$18.36-3.42%$18.43$18.36355 shs$20.20 million04/11/2024$18.90$19.01+0.58%$19.01$18.934,203 shs$20.91 million04/10/2024$19.04$18.90-0.74%$18.90$18.84750 shs$26.46 million04/09/2024$18.91$19.04+0.71%$19.04$18.994,367 shs$26.66 million04/08/2024$18.90$18.91+0.01%$18.98$18.872,119 shs$26.47 million04/05/2024$18.98$18.90-0.42%$18.90$18.82758 shs$26.46 million04/04/2024$19.06$18.98-0.42%$19.15$18.9818,468 shs$26.57 million04/03/2024$19.16$19.06-0.52%$19.08$19.043,729 shs$26.68 million04/02/2024$19.11$19.16+0.26%$19.26$19.15872 shs$26.82 million04/01/2024$18.79$19.11+1.70%$19.15$19.107,571 shs$26.75 million03/29/2024$18.79$18.79$18.83$18.791,877 shs$26.31 million03/28/2024$18.63$18.79+0.86%$18.83$18.791,877 shs$26.31 million03/27/2024$18.69$18.63-0.32%$18.63$18.561,009 shs$26.08 million03/26/2024$18.61$18.69+0.46%$18.69$18.675,273 shs$26.17 million03/25/2024$18.62$18.61-0.06%$18.61$18.582,227 shs$26.05 million03/22/2024$18.95$18.62-1.74%$18.66$18.531,314 shs$26.07 million03/21/2024$19.08$18.95-0.69%$18.99$18.931,649 shs$26.53 million03/20/2024$18.90$19.08+0.96%$19.10$18.986,205 shs$26.71 million03/19/2024$19.00$18.90-0.53%$18.92$18.842,543 shs$26.46 million03/18/2024$18.85$19.00+0.79%$19.08$18.9228,395 shs$26.60 million03/15/2024$18.92$18.85-0.37%$18.91$18.851,391 shs$26.39 million03/14/2024$19.24$18.92-1.66%$18.92$18.87412 shs$26.49 million03/13/2024$19.21$19.24+0.17%$19.35$19.244,227 shs$26.94 million03/12/2024$18.69$19.21+2.74%$19.23$19.165,277 shs$26.89 million03/11/2024$18.19$18.69+2.77%$18.75$18.69711 shs$26.17 million03/08/2024$18.14$18.23+0.50%$18.23$18.161,209 shs$25.52 million03/07/2024$18.39$18.14-1.38%$18.14$18.053,301 shs$25.40 million03/06/2024$18.02$18.39+2.05%$18.47$18.381,940 shs$25.75 million03/05/2024$18.29$18.02-1.45%$18.04$18.011,688 shs$25.23 million03/04/2024$18.62$18.29-1.78%$18.50$18.245,289 shs$25.60 millionWhy Big Pharma is Investing Billions in This Biotech (Ad)If you're on the hunt for a great biotech stock under $20... you need to see this video.Watch my exclusive report here>>>03/01/2024$18.26$18.62+1.97%$18.64$18.576,496 shs$26.07 million02/29/2024$18.16$18.26+0.55%$18.31$18.262,600 shs$25.56 million02/28/2024$18.74$18.16-3.10%$18.19$18.141,494 shs$25.42 million02/27/2024$18.60$18.74+0.76%$18.77$18.74379 shs$26.24 million02/26/2024$18.74$18.60-0.76%$18.62$18.602,434 shs$26.04 million02/23/2024$18.66$18.74+0.44%$18.78$18.68900 shs$26.24 million02/22/2024$18.46$18.66+1.11%$18.69$18.571,048 shs$26.12 million02/21/2024$18.00$18.46+2.53%$18.47$18.46889 shs$25.84 million02/20/2024$18.22$18.00-1.21%$18.20$17.972,184 shs$25.20 million02/19/2024$18.22$18.22+0.03%$18.28$18.221,200 shs$25.51 million02/16/2024$17.84$18.22+2.13%$18.28$18.221,237 shs$25.51 million02/15/2024$17.77$17.84+0.39%$17.97$17.7826,579 shs$24.98 million02/14/2024$17.52$17.77+1.43%$17.79$17.6311,477 shs$24.88 million02/13/2024$17.86$17.52-1.90%$17.65$17.5111,014 shs$24.53 million02/12/2024$17.60$17.86+1.50%$17.98$17.844,333 shs$25.00 million02/09/2024$17.45$17.60+0.86%$17.60$17.349,189 shs$24.64 million02/08/2024$17.78$17.45-1.86%$17.60$17.458,881 shs$24.43 million02/07/2024$17.99$17.78-1.17%$17.83$17.741,499 shs$24.89 million02/06/2024$17.12$17.99+5.07%$17.99$17.753,855 shs$25.19 million02/05/2024$16.84$17.12+1.64%$17.15$16.967,208 shs$23.97 million02/02/2024$17.18$16.84-1.98%$16.90$16.7722,650 shs$23.58 million02/01/2024$17.09$17.18+0.53%$17.29$17.146,747 shs$24.05 million01/31/2024$17.23$17.09-0.81%$17.24$17.0910,182 shs$23.93 million01/30/2024$17.55$17.23-1.82%$17.28$17.1310,978 shs$24.12 million01/29/2024$17.95$17.55-2.23%$17.74$17.5015,450 shs$24.57 million01/26/2024$18.11$17.95-0.88%$18.01$17.932,726 shs$25.13 million Related Companies: ProShares Inflation Expectations ETF Stock Price Chart Counterpoint Quantitative Equity ETF Stock Price Chart Overlay Shares Municipal Bond ETF Stock Price Chart Franklin FTSE Germany ETF Stock Price Chart Rayliant SMDAM Japan Equity ETF Stock Price Chart iShares MSCI Belgium ETF Stock Price Chart American Century Multisector Floating Income ETF Stock Price Chart Hartford Multifactor Emerging Markets ETF Stock Price Chart Goldman Sachs ActiveBeta Japan Equity ETF Stock Price Chart Franklin FTSE Saudi Arabia ETF Stock Price Chart Receive MCH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Matthews China Active ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:MCH) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace4 Cryptos BETTER than BitcoinTrue Market InsidersThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Matthews China Active ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.